This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre Hospitalier Universitaire De Montpellier, Institut Regional Du Cancer De Montpellier, Universitè De Montpellier. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2018
Title: Jerome Lacombe: Innovator in Radiosensitivity Determination
Introduction
Jerome Lacombe is a notable inventor based in Saint-Gély-du-Fesc, France. He has made significant contributions to the field of medical research, particularly in the area of radiosensitivity. His innovative approach has led to the development of a unique method that has potential applications in predicting patient responses to radiation therapy.
Latest Patents
Lacombe holds a patent for a method titled "Method for determining radiosensitivity." This invention relates to an in vitro technique for assessing the radiosensitivity of a subject. The method involves inducing an exogenous stress on a biological sample from the subject and comparing the presence or level of specific compounds in the sample against a reference sample. Additionally, the invention identifies at least one compound as a predictive biomarker for radiosensitivity. A kit for detecting these compounds is also included in the patent.
Career Highlights
Throughout his career, Jerome Lacombe has been associated with prestigious institutions such as Université de Montpellier and Centre Hospitalier Universitaire de Montpellier. His work in these organizations has allowed him to advance his research and collaborate with other experts in the field.
Collaborations
Lacombe has worked alongside notable colleagues, including David Azria and Jérôme Solassol. Their combined expertise has contributed to the development of innovative solutions in medical research.
Conclusion
Jerome Lacombe's contributions to the field of radiosensitivity determination highlight his role as an influential inventor. His patented method and collaborative efforts with esteemed colleagues underscore the importance of innovation in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile